Shan Zhu
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- Immunology top 2%
- Immune cells in cancer
Papers in
-
- Epigenetics and DNA Methylation 5
- Histone Deacetylase Inhibitors Research 4
- Oncology 17
- Cancer-related Molecular Pathways 5
- Co-authors
- Rui Kang (14 shared papers)Daolin Tang (14 shared papers)Timothy R. Billiar (9 shared papers)Haichao Wang (8 shared papers)Guido Kroemer (7 shared papers)Yangchun Xie (5 shared papers)Herbert J. Zeh (8 shared papers)Ling Zeng (6 shared papers)
- Journals
- Oncotarget (9 papers)Frontiers in Immunology (6 papers)Protein & Cell (2 papers)Proceedings of the National Academy of Sciences (2 papers)Pharmacological Research (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Shan Zhu
83 papers receiving 5.3k citations
Shan Zhu's Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 1.1k
- Immunology 1.0k
- Molecular Biology 2.7k
- Pulmonary and Respiratory Medicine 1.0k
- Neurology 255
Countries citing papers authored by Shan Zhu
This map shows the geographic impact of Shan Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Zhu more than expected).
Fields of papers citing papers by Shan Zhu
This network shows the impact of papers produced by Shan Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Zhu. The network helps show where Shan Zhu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shan Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System Xc– Activity Hit paper breakdown → | 2018 | 603 |
| 2 | Lipid Peroxidation Drives Gasdermin D-Mediated Pyroptosis in Lethal Polymicrobial Sepsis Hit paper breakdown → | 2018 | 500 |
| 3 | PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation Hit paper breakdown → | 2016 | 449 |
| 4 | 2003 | 354 | |
| 5 | 2017 | 252 | |
| 6 | 2017 | 179 | |
| 7 | 2017 | 158 | |
| 8 | 2009 | 130 | |
| 9 | 2018 | 128 | |
| 10 | 2021 | 124 | |
| 11 | 2019 | 118 | |
| 12 | 2017 | 115 | |
| 13 | 2017 | 114 | |
| 14 | 2014 | 107 | |
| 15 | 2017 | 105 | |
| 16 | 2008 | 101 | |
| 17 | 2004 | 95 | |
| 18 | 2011 | 82 | |
| 19 | 2011 | 82 | |
| 20 | 2018 | 68 |
About Shan Zhu
Shan Zhu is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Epidemiology, having authored 87 papers that have together received 5.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), Immune Cell Function and Interaction (6 papers), Epigenetics and DNA Methylation (5 papers), Immunotherapy and Immune Responses (5 papers), Cancer-related Molecular Pathways (5 papers), MicroRNA in disease regulation (5 papers), Immune Response and Inflammation (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Cancer Research (1.1k citations), Immunology (1.0k citations), Molecular Biology (2.7k citations), Pulmonary and Respiratory Medicine (1.0k citations) and Neurology (255 citations). Shan Zhu has collaborated with scholars based in China, United States and France. Frequent co-authors include Rui Kang, Daolin Tang, Timothy R. Billiar, Haichao Wang, Guido Kroemer, Yangchun Xie, Herbert J. Zeh, Ling Zeng, Lizhi Cao and Jianxin Jiang. Their work appears in journals such as Oncotarget, Frontiers in Immunology, Protein & Cell, Proceedings of the National Academy of Sciences and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.